Nasdaq Stockholm

AstraZeneca PLC

ISIN GB0009895292Filings at the FINYSE: AZNCIK 0000901832Filings at SEC EDGAR

At a glance

Most recent filing on September 17, 2026 — an open-market purchase by Pascal Soriot on Sep 14, 2026.

We hold 49 visible filings, going back to March 23, 2021.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 49 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 49. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Pascal Soriot Chief executive officer
7,261,200 GBPOpen-market buy
TradedSep 14, 2026FiledSep 17, 2026
Michel Demare Chair of the board
303,033 GBPOpen-market buy
TradedSep 14, 2026FiledSep 15, 2026
Aradhana Sarin Chief financial officer
6,461,541 GBPGrant
TradedMar 4, 2026FiledMar 6, 2026
Pascal Soriot Chief executive officer
15,787,816 GBPGrant
TradedMar 4, 2026FiledMar 6, 2026
Nazneen Rahman Board member
40,083 GBPOpen-market sale
TradedDec 18, 2025FiledDec 19, 2025

In the United States

AstraZeneca PLC is also listed in the United States (NYSE: AZN) and files with the SEC under CIK 0000901832. What the U.S. registers hold for it is below.

Insider trades

How to read a Form 4

All 5 shown

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. So are the trades members of Congress reported in this company and the funds that reported holding it in their 13F filings. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Sharma Mani See remarks
$320Grant
TradedOct 6, 2026FiledOct 8, 2026
Sharma Mani See Remarks
$163Grant
TradedSep 8, 2026FiledSep 11, 2026
Sharma Mani See Remarks
$3,249Open-market buy
TradedAug 8, 2026FiledSep 11, 2026
Sharma Mani SVP, Group Controller
$327Grant
TradedAug 6, 2026FiledAug 7, 2026
Sharma Mani See Remarks
$381Grant
TradedJul 6, 2026FiledJul 8, 2026

Lobby

All filings

Q3 2026$160kthrough two registrants

Since Q4 2009$7.81Mover 68 quarters, 136 reports

Reported per quarterIn-houseOutside registrants

Q4 2009Q1 2013Q3 2016Q4 2019Q2 2023Q3 2026